STAR Therapeutics
Homepage
STAR Therapeutics was founded in 2018, is headquartered in San Francisco, United States, lists 11–50 employees, and has $215.0M in recorded funding across 2 rounds.
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- star-therapeutics.com
- Total Funding
- $215.0M
- Last Round
- $125.0M Series DSep 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 9 investors for this company. The full record is or through the API.
About
STAR Therapeutics is a clinical-stage biotechnology company founded in 2018 by Adam Rosenthal, PhD, and headquartered in South San Francisco, California. The company discovers and develops best-in-class antibody therapies to transform the lives of patients with serious diseases. STAR's distinctive pipeline is built on novel biology that enables a pipeline-in-a-product strategy, with lead program VEGA focused on von Willebrand disease (VWD) and other bleeding disorders. VGA039, the company's lead antibody candidate, has received FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VWD prophylaxis and is currently in Phase 3 clinical evaluation. The leadership team brings deep expertise having previously invented four first-in-class antibodies, including ENJAYMO — the first approved therapy for cold agglutinin disease. STAR is backed by prominent life sciences investors including OrbiMed, Redmile Group, and Sofinnova Investments.
Summary
STAR Therapeutics is a Biotech company based in San Francisco, United States, founded in 2018. It lists 11–50 employees. It has raised $215.0M in total across 2 rounds, most recently a $125.0M Series D round in Sep 2025. Investors include Sanofi Ventures, Viking Global and Sofinnova Investments.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Sign up to see all 2 events
Funding: Series C through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/star-therapeutics"><img src="https://indexed.vc/api/badge/company/star-therapeutics" alt="STAR Therapeutics on Indexed.vc" width="260" height="76" /></a>